Clinical Trial: Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07221513) titled 'Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension' on Aug. 20.

Brief Summary: This is a Phase 2a, open-label, multiple-dose study to assess the safety, tolerability, and efficacy of JK07 in participants 18 to 85 years of age with diagnosed HF and cpcPH.

At least 20 and up to approximately 30 participants will be enrolled and receive JK07 high dose in this open-label trial.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: HFrEF - Heart Failure With Reduced Ejection Fraction HFpEF - Heart Failure With Preserved Ejection Fraction Group 2 Pulmonary...